{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:03:19Z","timestamp":1790388199457,"version":"4.1.0"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,12,1]]},"DOI":"10.1093\/rheumatology\/kei082","type":"journal-article","created":{"date-parts":[[2005,11,2]],"date-time":"2005-11-02T01:24:17Z","timestamp":1130894657000},"page":"1546-1548","source":"Crossref","is-referenced-by-count":140,"title":["Increase in bone mineral density of patients with rheumatoid arthritis treated with anti-TNF-\u03b1 antibody: a prospective open-label pilot study"],"prefix":"10.1093","volume":"44","author":[{"given":"U.","family":"Lange","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Teichmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Mu\u0308ller-Ladner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Strunk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2005,11,1]]},"reference":[{"key":"key\n\t\t\t\t20171012051429_BIB1","doi-asserted-by":"crossref","unstructured":"Dequeker J, Maenaut K, Verwilghen J, Westhovens R. Osteoporosis in rheumatoid arthritis: a review. Br J Rheumatol1996;35:309\u201322.","DOI":"10.1093\/rheumatology\/35.4.309"},{"key":"key\n\t\t\t\t20171012051429_BIB2","doi-asserted-by":"crossref","unstructured":"Gough AKS, Lilley J, Eyre S, Holder RL, Emery P. Generalized bone loss in patients with early rheumatoid arthritis. Lancet1994;344:23\u20137.","DOI":"10.1016\/S0140-6736(94)91049-9"},{"key":"key\n\t\t\t\t20171012051429_BIB3","unstructured":"Feldmann M, Brennan FM, Field M, Maini RN. Pathogenesis of rheumatoid arthritis: cellular and cytokine interactions. In: Smolen J, Kalden JR, Maini RN, eds. Recent advances in rheumatoid arthritis. Berlin: Springer Verlag, 1990;850\u2013974."},{"key":"key\n\t\t\t\t20171012051429_BIB4","doi-asserted-by":"crossref","unstructured":"Lipsky PE, Davis LS, Cush JJ, Oppenheimer-Marks N. The role of cytokines in the pathogenesis of rheumatoid arthritis. Springer Semin Immunopathol1989;11:187\u201398.","DOI":"10.1007\/BF00197186"},{"key":"key\n\t\t\t\t20171012051429_BIB5","doi-asserted-by":"crossref","unstructured":"Sambrook PN, Cohen ML, Eisman JA, Pocock NA, Champion GD, Yeates MG. Effects of low dose corticosteroids on bone mass in rheumatoid arthritis: a longitudinal study. Ann Rheum Dis1989;48:535.","DOI":"10.1136\/ard.48.7.535"},{"key":"key\n\t\t\t\t20171012051429_BIB6","unstructured":"Reid IR. Glucocorticoid-induced osteoporosis and other forms of secondary osteoporosis. In: Meunier PJ, ed. Osteoporosis: diagnosis and management. London: Martin Dunitz, 1998;233\u201350."},{"key":"key\n\t\t\t\t20171012051429_BIB7","unstructured":"Ringe J. Pathogenese der Kortikosteroidosteoporose. Fortschr Med1990;108:393\u20136."},{"key":"key\n\t\t\t\t20171012051429_BIB8","doi-asserted-by":"crossref","unstructured":"Allali F, Breban M, Porcher R, Maillefert JF, Dougados M, Roux C. Increase in bone mineral density of patients with spondylarthropathy treated with anti-tumour necrosis factor \u03b1. Ann Rheum Dis2003;62:347\u20139.","DOI":"10.1136\/ard.62.4.347"},{"key":"key\n\t\t\t\t20171012051429_BIB9","doi-asserted-by":"crossref","unstructured":"Ammann P, Rizzoli R, Bonjour JP, Bourrin S, Meyer JM, Vassalli P. Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency. J Clin Invest1997;99:1699\u2013703.","DOI":"10.1172\/JCI119333"},{"key":"key\n\t\t\t\t20171012051429_BIB10","unstructured":"Lipsky PE, van der Heijde DM, St Clair EW et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N Engl J Med2000;343:594\u2013602."},{"key":"key\n\t\t\t\t20171012051429_BIB11","unstructured":"Doubremelle M, Bourreille A, Zerbib F et al. Treatment of Crohn's disease with anti-TNF alpha antibodies (infliximab). Results of a multicentric and retrospective study. Gastroenterol Clin Biol2002;26:973\u20139."},{"key":"key\n\t\t\t\t20171012051429_BIB12","doi-asserted-by":"crossref","unstructured":"Braun J, Brandt J, Listing J et al. Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial. Lancet2002;359:1187\u201393.","DOI":"10.1016\/S0140-6736(02)08215-6"},{"key":"key\n\t\t\t\t20171012051429_BIB13","doi-asserted-by":"crossref","unstructured":"Arnett FC, Edworthy SM, Block DA. The American Rheumatism Association 1987 Revised Criteria for the Classification of Rheumatoid Arthritis; Arthritis Rheum1988;31:315\u201324.","DOI":"10.1002\/art.1780310302"},{"key":"key\n\t\t\t\t20171012051429_BIB14","doi-asserted-by":"crossref","unstructured":"Glu\u0308er CC, Blake G, Lu Y et al. Accurate assessment of precision errors: how to measure the reproducibility of bone densitometry techniques. Osteoporosis Int1995;5:262\u201380.","DOI":"10.1007\/BF01774016"},{"key":"key\n\t\t\t\t20171012051429_BIB15","doi-asserted-by":"crossref","unstructured":"Lange U, Boss B, Teichmann J, Stracke H, Neeck G. Bone mineral density and biochemical markers of bone metabolism in late onset rheumatoid arthritis and polymyalgia rheumatica\u2014a prospective study. Z Rheumatol2000;59(Suppl. 2):137\u201341.","DOI":"10.1007\/PL00022856"},{"key":"key\n\t\t\t\t20171012051429_BIB16","doi-asserted-by":"crossref","unstructured":"Lane NE, Pressman AR, Star VL, Cummings SR, Nevitt MC. Rheumatoid arthritis and bone mineral density in elderly women. J Bone Min Res1995;10:257\u201363.","DOI":"10.1002\/jbmr.5650100212"},{"key":"key\n\t\t\t\t20171012051429_BIB17","doi-asserted-by":"crossref","unstructured":"Star VL, Hochberg MC. Osteoporosis in patients with rheumatic diseases. Rheum Dis Clin N Am1994;20:561\u201376.","DOI":"10.1016\/S0889-857X(21)00349-5"},{"key":"key\n\t\t\t\t20171012051429_BIB18","doi-asserted-by":"crossref","unstructured":"Oelzner P, Mu\u0308ller A, Deschner F et al. Relationship between disease activity and serum levels of vitamin D metabolites and PTH in rheumatoid arthritis. Calcif Tissue Int1998;62:193\u20138.","DOI":"10.1007\/s002239900416"},{"key":"key\n\t\t\t\t20171012051429_BIB19","doi-asserted-by":"crossref","unstructured":"Kimble RB, Bain S, Pacifica R. The functional block of TNF but not of IL6 prevents bone loss in ovariectomized mice. J Bone Min Res1997;12:935\u201341.","DOI":"10.1359\/jbmr.1997.12.6.935"},{"key":"key\n\t\t\t\t20171012051429_BIB20","doi-asserted-by":"crossref","unstructured":"Bertolini DR, Nedwin GE, Bringman TS, Smith DD, Mundy GR. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumor necrosis factor. Nature1986;319:516\u20138.","DOI":"10.1038\/319516a0"},{"key":"key\n\t\t\t\t20171012051429_BIB21","doi-asserted-by":"crossref","unstructured":"Brandstrom H, Bjorkman T, Ljunggren O. Regulation of osteoprotegerin secretion: from primary cultures of human bone marrow stromal cells. Biochem Biophys Res Commun2001;280:831\u20135.","DOI":"10.1006\/bbrc.2000.4223"},{"key":"key\n\t\t\t\t20171012051429_BIB22","doi-asserted-by":"crossref","unstructured":"Black DM, Thompson DE, Bauer DC et al. Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Interventional Trial. FIT Research Group. J Clin Endocrinol Metabol2000;85:4118\u201324.","DOI":"10.1210\/jcem.85.11.6953"},{"key":"key\n\t\t\t\t20171012051429_BIB23","doi-asserted-by":"crossref","unstructured":"Reginster J, Minne HW, Sorensen OH et al. Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. Osteoporos Int2000;11:83\u201391.","DOI":"10.1007\/s001980050010"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/44\/12\/1546\/9446372\/kei082.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T01:00:04Z","timestamp":1626656404000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/rheumatology\/article\/44\/12\/1546\/2891515\/Increase-in-bone-mineral-density-of-patients-with"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,1]]},"references-count":23,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2005,11,1]]},"published-print":{"date-parts":[[2005,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/kei082","relation":{},"ISSN":["1462-0332","1462-0324"],"issn-type":[{"value":"1462-0332","type":"electronic"},{"value":"1462-0324","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,12]]},"published":{"date-parts":[[2005,11,1]]}}}